Vermillion (VRML +54.1%) shares soar after the molecular diagnostics company says it received...

|By:, SA News Editor

Vermillion (VRML +54.1%) shares soar after the molecular diagnostics company says it received Category 1 CPT Code approval for OVA1 test designed to help differentiate benign vs. malignant ovarian masses. VRML also says it received a notice of allowance from the U.S. Patent and Trademark Office for a patent for "platelet biomarkers for cancer."